4//SEC Filing
Jazz Pharmaceuticals plc 4
Accession 0001232524-14-000146
$JAZZCIK 0001232524operating
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 6:51 PM ET
Size
5.1 KB
Accession
0001232524-14-000146
Insider Transaction Report
Form 4
Tobias Jeffrey K
SVP of Research & Dev and CMO
Transactions
- Sale
Ordinary Shares
2014-11-24$170.12/sh−4,598$782,231→ 34,940 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $169.76 to $170.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeoperating
IncorporatedIreland
Related Parties
1- filerCIK 0001232524
Filing Metadata
- Form type
- 4
- Filed
- Nov 24, 7:00 PM ET
- Accepted
- Nov 25, 6:51 PM ET
- Size
- 5.1 KB